{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:52:49Z","timestamp":1773287569627,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science, and Technology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Korean Health Technology R&amp;D Project, Ministry of Health &amp; Welfare, Republic of Korea"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Endocan is a water-soluble proteoglycan exclusively secreted by vascular endothelium. Endocan levels may be elevated in kidney transplant recipients experiencing antibody-mediated rejection (ABMR), which is characterized by vascular inflammation in transplanted kidney. We evaluated the clinical relevance of endocan as markers of microvascular inflammation in patients who underwent kidney transplantation. Plasma and urinary endocan levels were measured in 203 kidney transplant recipients and were compared across different etiologies of allograft dysfunction and various pathologic scores. Both plasma and urinary endocan levels were significantly higher in patients with acute ABMR than those in patients with normal pathology, acute tubular necrosis (ATN), acute pyelonephritis, BK virus associated nephropathy (BKVN), and T-cell mediated rejection (TCMR). Patients with chronic active ABMR also exhibited significantly higher plasma and urinary endocan levels than patients with long-term graft survival. Scores of glomerulitis and peritubular capillaritis, which are typical features of microvascular inflammation, were significantly elevated in patients with higher plasma and\/or urinary endocan levels. Furthermore, plasma and urinary endocan levels could effectively discriminate ABMR from ATN, BKVN, and TCMR. Finally, patients exhibiting high urinary and plasma endocan levels in acute ABMR group showed significantly worse renal survival. Altogether, plasma and urinary endocan levels may serve as potential markers of microvascular inflammation in kidney transplant recipients.<\/jats:p>","DOI":"10.1038\/s41598-018-37975-9","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T11:05:20Z","timestamp":1549969520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Endocan as a marker of microvascular inflammation in kidney transplant recipients"],"prefix":"10.1038","volume":"9","author":[{"given":"Yu Ho","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se-Yun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haena","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Woo","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seon Hwa","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang-Gyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Young","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Sug","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Hwan","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Jig","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan-Duck","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Berm","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0048-5717","authenticated-orcid":false,"given":"Byung Ha","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeong Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaeseok","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung-In","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoung Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,12]]},"reference":[{"issue":"Suppl 2","key":"37975_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ajt.13195","volume":"15","author":"AJ Matas","year":"2015","unstructured":"Matas, A. J. et al. OPTN\/SRTR 2013 Annual Data Report: kidney. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 15(Suppl 2), 1\u201334, https:\/\/doi.org\/10.1111\/ajt.13195 (2015).","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"key":"37975_CR2","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1111\/j.1600-6143.2009.02799.x","volume":"9","author":"G Einecke","year":"2009","unstructured":"Einecke, G. et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am. J. Transplant. 9, 2520\u20132531, https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02799.x (2009).","journal-title":"Am. J. Transplant."},{"key":"37975_CR3","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1111\/j.1600-6143.2010.03261.x","volume":"10","author":"I Batal","year":"2010","unstructured":"Batal, I. et al. A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies. Am. J. Transplant. 10, 2442\u20132452, https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03261.x (2010).","journal-title":"Am. J. Transplant."},{"key":"37975_CR4","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1097\/TP.0b013e3181ff87f5","volume":"90","author":"JC Papadimitriou","year":"2010","unstructured":"Papadimitriou, J. C. et al. Glomerular inflammation in renal allografts biopsies after the first year: cell types and relationship with antibody-mediated rejection and graft outcome. Transplantation 90, 1478\u20131485, https:\/\/doi.org\/10.1097\/TP.0b013e3181ff87f5 (2010).","journal-title":"Transplantation"},{"key":"37975_CR5","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1111\/j.1600-6143.2011.03931.x","volume":"12","author":"B Sis","year":"2012","unstructured":"Sis, B. et al. A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am. J. Transplant. 12, 1168\u20131179, https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03931.x (2012).","journal-title":"Am. J. Transplant."},{"key":"37975_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5500\/wjt.v4.i1.1","volume":"4","author":"M Salvadori","year":"2014","unstructured":"Salvadori, M. & Bertoni, E. Impact of donor-specific antibodies on the outcomes of kidney graft: pathophysiology, clinical, therapy. World J. Transplant. 4, 1\u201317, https:\/\/doi.org\/10.5500\/wjt.v4.i1.1 (2014).","journal-title":"World J. Transplant."},{"key":"37975_CR7","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1097\/TP.0000000000001403","volume":"101","author":"H Ishihara","year":"2017","unstructured":"Ishihara, H. et al. Evaluation of Microvascular Inflammation in ABO-Incompatible Kidney Transplantation. Transplantation 101, 1423\u20131432, https:\/\/doi.org\/10.1097\/TP.0000000000001403 (2017).","journal-title":"Transplantation"},{"key":"37975_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2215\/CJN.00700117","volume":"13","author":"R Zhang","year":"2017","unstructured":"Zhang, R. Donor-specific antibodies in kidney transplant recipients. Clin. J. Am. Soc. Nephrol. 13, 182\u2013192, https:\/\/doi.org\/10.2215\/CJN.00700117 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"37975_CR9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1600-6143.2012.04325.x","volume":"13","author":"H de Kort","year":"2013","unstructured":"de Kort, H. et al. Microcirculation inflammation associates with outcome in renal transplant patients with de novo donor-specific antibodies. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 13, 485\u2013492, https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04325.x (2013).","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"key":"37975_CR10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/ajt.12590","volume":"14","author":"M Haas","year":"2014","unstructured":"Haas, M. et al. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am. J. Transplant. 14, 272\u2013283, https:\/\/doi.org\/10.1111\/ajt.12590 (2014).","journal-title":"Am. J. Transplant."},{"key":"37975_CR11","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1111\/j.1600-6143.2011.03647.x","volume":"11","author":"M Haas","year":"2011","unstructured":"Haas, M. & Mirocha, J. Early ultrastructural changes in renal allografts: correlation with antibody-mediated rejection and transplant glomerulopathy. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 11, 2123\u20132131, https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03647.x (2011).","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"key":"37975_CR12","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1681\/ASN.2007101056","volume":"19","author":"J Ashton-Chess","year":"2008","unstructured":"Ashton-Chess, J. et al. Tribbles-1 as a novel biomarker of chronic antibody-mediated rejection. Journal of the American Society of Nephrology: JASN 19, 1116\u20131127, https:\/\/doi.org\/10.1681\/ASN.2007101056 (2008).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"37975_CR13","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/ki.2012.200","volume":"82","author":"F Haidar","year":"2012","unstructured":"Haidar, F. & Issa, N. C4d deposits on erythrocytes (EC4d): a new biomarker of antibody-mediated rejection in kidney transplantation. Kidney international 82, 490\u2013491, https:\/\/doi.org\/10.1038\/ki.2012.200 (2012).","journal-title":"Kidney international"},{"key":"37975_CR14","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1111\/ajt.12465","volume":"13","author":"PF Halloran","year":"2013","unstructured":"Halloran, P. F. et al. Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM). American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 13, 2865\u20132874, https:\/\/doi.org\/10.1111\/ajt.12465 (2013).","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"key":"37975_CR15","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1681\/ASN.2014080797","volume":"26","author":"M Rabant","year":"2015","unstructured":"Rabant, M. et al. Urinary C-X-C Motif Chemokine 10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection. Journal of the American Society of Nephrology: JASN 26, 2840\u20132851, https:\/\/doi.org\/10.1681\/ASN.2014080797 (2015).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"37975_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/1354750x.2016.1204000","volume":"22","author":"K Iwasaki","year":"2017","unstructured":"Iwasaki, K. et al. MiR-142-5p and miR-486-5p as biomarkers for early detection of chronic antibody-mediated rejection in kidney transplantation. Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals 22, 45\u201354, https:\/\/doi.org\/10.1080\/1354750x.2016.1204000 (2017).","journal-title":"Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals"},{"key":"37975_CR17","doi-asserted-by":"publisher","unstructured":"Noro, D. et al. Serum Aberrant N-Glycan Profile as a Marker Associated with Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant. International journal of molecular sciences 18, https:\/\/doi.org\/10.3390\/ijms18081731 (2017).","DOI":"10.3390\/ijms18081731"},{"key":"37975_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/ki.2015.276","volume":"89","author":"A Gupta","year":"2016","unstructured":"Gupta, A. et al. Clinical and molecular significance of microvascular inflammation in transplant kidney biopsies. Kidney international 89, 217\u2013225, https:\/\/doi.org\/10.1038\/ki.2015.276 (2016).","journal-title":"Kidney international"},{"key":"37975_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bbcan.2005.08.004","volume":"1765","author":"S Sarrazin","year":"2006","unstructured":"Sarrazin, S. et al. Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim. Biophys. Acta 1765, 25\u201337, https:\/\/doi.org\/10.1016\/j.bbcan.2005.08.004 (2006).","journal-title":"Biochim. Biophys. Acta"},{"key":"37975_CR20","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/jcp.24485","volume":"229","author":"W Lee","year":"2014","unstructured":"Lee, W., Ku, S. K., Kim, S. W. & Bae, J. S. Endocan elicits severe vascular inflammatory responses in vitro and in vivo. J. Cell. Physiol. 229, 620\u2013630, https:\/\/doi.org\/10.1002\/jcp.24485 (2014).","journal-title":"J. Cell. Physiol."},{"key":"37975_CR21","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/SHK.0000000000000320","volume":"43","author":"LA Cox","year":"2015","unstructured":"Cox, L. A. et al. Inflammation-induced increases in plasma endocan levels are associated with endothelial dysfunction in humans in vivo. Shock 43, 322\u2013326, https:\/\/doi.org\/10.1097\/SHK.0000000000000320 (2015).","journal-title":"Shock"},{"key":"37975_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.clinbiochem.2015.01.006","volume":"48","author":"K Pawlak","year":"2015","unstructured":"Pawlak, K., Mysliwiec, M. & Pawlak, D. Endocan\u2013the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease. Clin. Biochem. 48, 425\u2013430, https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.01.006 (2015).","journal-title":"Clin. Biochem."},{"key":"37975_CR23","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1177\/0003319717740781","volume":"69","author":"I Balamir","year":"2018","unstructured":"Balamir, I., Ates, I., Topcuoglu, C. & Turhan, T. Association of endocan, ischemia-modified albumin, and hsCRP levels with endothelial dysfunction in Type 2 Diabetes Mellitus. Angiology 69, 609\u2013616, https:\/\/doi.org\/10.1177\/0003319717740781 (2018).","journal-title":"Angiology"},{"key":"37975_CR24","doi-asserted-by":"publisher","unstructured":"Musialowska, D., Zbroch, E., Koc-Zorawska, E., Musialowski, P. & Malyszko, J. Endocan Concentration in Patients With Primary Hypertension. Angiology, 3319717736158, https:\/\/doi.org\/10.1177\/0003319717736158 (2017).","DOI":"10.1177\/0003319717736158"},{"issue":"738","key":"37975_CR25","doi-asserted-by":"publisher","first-page":"e731","DOI":"10.1016\/j.urology.2012.03.019","volume":"80","author":"S Li","year":"2012","unstructured":"Li, S. et al. Detection on dynamic changes of endothelial cell specific molecule-1 in acute rejection after renal transplantation. Urology 80(738), e731\u2013738, https:\/\/doi.org\/10.1016\/j.urology.2012.03.019 (2012).","journal-title":"Urology"},{"key":"37975_CR26","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","volume":"8","author":"K Solez","year":"2008","unstructured":"Solez, K. et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am. J. Transplant. 8, 753\u2013760, https:\/\/doi.org\/10.1111\/j.1600-6143.2008.02159.x (2008).","journal-title":"Am. J. Transplant."},{"key":"37975_CR27","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1365-2559.2009.03458.x","volume":"56","author":"X Leroy","year":"2010","unstructured":"Leroy, X. et al. Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma. Histopathology 56, 180\u2013187, https:\/\/doi.org\/10.1111\/j.1365-2559.2009.03458.x (2010).","journal-title":"Histopathology"},{"key":"37975_CR28","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1111\/j.1600-6143.2010.03268.x","volume":"10","author":"PF Halloran","year":"2010","unstructured":"Halloran, P. F. et al. An integrated view of molecular changes, histopathology and outcomes in kidney transplants. Am. J. Transplant. 10, 2223\u20132230 (2010).","journal-title":"Am. J. Transplant."},{"key":"37975_CR29","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1161\/01.ATV.0000085630.24353.3D","volume":"23","author":"AA Constantinescu","year":"2003","unstructured":"Constantinescu, A. A., Vink, H. & Spaan, J. A. Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface. Arterioscler. Thromb. Vasc. Biol. 23, 1541\u20131547, https:\/\/doi.org\/10.1161\/01.ATV.0000085630.24353.3D (2003).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"37975_CR30","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S0272-6386(03)00906-5","volume":"42","author":"M Koc","year":"2003","unstructured":"Koc, M., Bihorac, A. & Segal, M. S. Circulating endothelial cells as potential markers of the state of the endothelium in hemodialysis patients. Am. J. Kidney Dis. 42, 704\u2013712 (2003).","journal-title":"Am. J. Kidney Dis."},{"issue":"Suppl 1","key":"37975_CR31","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.3109\/1354750x.2011.587893","volume":"16","author":"P Paulus","year":"2011","unstructured":"Paulus, P., Jennewein, C. & Zacharowski, K. Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis. Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals 16(Suppl 1), S11\u2013S21, https:\/\/doi.org\/10.3109\/1354750x.2011.587893 (2011).","journal-title":"Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals"},{"key":"37975_CR32","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1172\/JCI61495","volume":"122","author":"X Sun","year":"2012","unstructured":"Sun, X. et al. MicroRNA-181b regulates NF-kappaB-mediated vascular inflammation. J. Clin. Invest. 122, 1973\u20131990, https:\/\/doi.org\/10.1172\/JCI61495 (2012).","journal-title":"J. Clin. Invest."},{"key":"37975_CR33","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nri1702","volume":"5","author":"RB Colvin","year":"2005","unstructured":"Colvin, R. B. & Smith, R. N. Antibody-mediated organ-allograft rejection. Nat. Rev. Immunol. 5, 807\u2013817, https:\/\/doi.org\/10.1038\/nri1702 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"37975_CR34","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3389\/fimmu.2014.00505","volume":"5","author":"G Piotti","year":"2014","unstructured":"Piotti, G., Palmisano, A., Maggiore, U. & Buzio, C. Vascular endothelium as a target of immune response in renal transplant rejection. Front. Immunol. 5, 505, https:\/\/doi.org\/10.3389\/fimmu.2014.00505 (2014).","journal-title":"Front. Immunol."},{"key":"37975_CR35","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/MOT.0b013e3283489a5a","volume":"16","author":"PD Hughes","year":"2011","unstructured":"Hughes, P. D. & Cohney, S. J. Modifiers of complement activation for prevention of antibody-mediated injury to allografts. Curr. Opin. Organ Transplant. 16, 425\u2013433, https:\/\/doi.org\/10.1097\/MOT.0b013e3283489a5a (2011).","journal-title":"Curr. Opin. Organ Transplant."},{"key":"37975_CR36","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.4049\/jimmunol.167.6.3099","volume":"167","author":"D B\u00e9chard","year":"2001","unstructured":"B\u00e9chard, D. et al. Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a\/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1. J. Immunol. 167, 3099\u20133106, https:\/\/doi.org\/10.4049\/jimmunol.167.6.3099 (2001).","journal-title":"J. Immunol."},{"key":"37975_CR37","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1158\/1078-0432.CCR-06-0185","volume":"12","author":"BD Grigoriu","year":"2006","unstructured":"Grigoriu, B. D. et al. Endocan expression and relationship with survival in human non-small cell lung cancer. Clin. Cancer Res. 12, 4575\u20134582, https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-0185 (2006).","journal-title":"Clin. Cancer Res."},{"key":"37975_CR38","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s00404-013-2863-3","volume":"288","author":"MM El Behery","year":"2013","unstructured":"El Behery, M. M., Seksaka, M. A., Ibrahiem, M. A., Saleh, H. S. & El Alfy, Y. Clinicopathological correlation of endocan expression and survival in epithelial ovarian cancer. Arch. Gynecol. Obstet. 288, 1371\u20131376, https:\/\/doi.org\/10.1007\/s00404-013-2863-3 (2013).","journal-title":"Arch. Gynecol. Obstet."},{"key":"37975_CR39","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.jhep.2013.07.030","volume":"59","author":"M Ziol","year":"2013","unstructured":"Ziol, M. et al. ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma. J. Hepatol. 59, 1264\u20131270, https:\/\/doi.org\/10.1016\/j.jhep.2013.07.030 (2013).","journal-title":"J. Hepatol."},{"key":"37975_CR40","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/ki.2014.227","volume":"86","author":"MI Yilmaz","year":"2014","unstructured":"Yilmaz, M. I. et al. Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease. Kidney Int. 86, 1213\u20131220, https:\/\/doi.org\/10.1038\/ki.2014.227 (2014).","journal-title":"Kidney Int."},{"key":"37975_CR41","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1177\/0003319714548870","volume":"66","author":"M Kose","year":"2015","unstructured":"Kose, M. et al. Serum Endocan Level and the Severity of Coronary Artery Disease: A Pilot Study. Angiology 66, 727\u2013731, https:\/\/doi.org\/10.1177\/0003319714548870 (2015).","journal-title":"Angiology"},{"key":"37975_CR42","doi-asserted-by":"publisher","first-page":"5422","DOI":"10.3748\/wjg.v22.i23.5422","volume":"22","author":"Y Chang","year":"2016","unstructured":"Chang, Y. et al. Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer. World J. Gastroenterol. 22, 5422\u20135429, https:\/\/doi.org\/10.3748\/wjg.v22.i23.5422 (2016).","journal-title":"World J. Gastroenterol."},{"key":"37975_CR43","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.krcp.2016.07.001","volume":"35","author":"YH Lee","year":"2016","unstructured":"Lee, Y. H. et al. Plasma endocan level and prognosis of immunoglobulin A nephropathy. Kidney Res. Clin. Pract. 35, 152\u2013159, https:\/\/doi.org\/10.1016\/j.krcp.2016.07.001 (2016).","journal-title":"Kidney Res. Clin. Pract."},{"key":"37975_CR44","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jcrc.2015.09.019","volume":"31","author":"D Pauly","year":"2016","unstructured":"Pauly, D. et al. Endothelial cell-specific molecule-1\/endocan: diagnostic and prognostic value in patients suffering from severe sepsis and septic shock. J. Crit. Care 31, 68\u201375, https:\/\/doi.org\/10.1016\/j.jcrc.2015.09.019 (2016).","journal-title":"J. Crit. Care"},{"key":"37975_CR45","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.12659\/MSM.900693","volume":"23","author":"S Oka","year":"2017","unstructured":"Oka, S. et al. Serum endocan as a predictive marker for decreased urine volume in peritoneal dialysis patients. Med. Sci. Monit. 23, 1464\u20131470 (2017).","journal-title":"Med. Sci. Monit."},{"key":"37975_CR46","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.transproceed.2013.10.057","volume":"46","author":"YH Su","year":"2014","unstructured":"Su, Y. H. et al. Serum Endocan correlated with stage of chronic kidney disease and deterioration in renal transplant recipients. Transplant. Proc. 46, 323\u2013327, https:\/\/doi.org\/10.1016\/j.transproceed.2013.10.057 (2014).","journal-title":"Transplant. Proc."},{"key":"37975_CR47","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1097\/NEN.0b013e3181a52a7f","volume":"68","author":"CA Maurage","year":"2009","unstructured":"Maurage, C. A. et al. Endocan expression and localization in human glioblastomas. J. Neuropathol. Exp. Neurol. 68, 633\u2013641, https:\/\/doi.org\/10.1097\/NEN.0b013e3181a52a7f (2009).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"37975_CR48","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11060-014-1377-6","volume":"117","author":"F Matano","year":"2014","unstructured":"Matano, F. et al. Endocan, a new invasion and angiogenesis marker of pituitary adenomas. J. Neurooncol. 117, 485\u2013491, https:\/\/doi.org\/10.1007\/s11060-014-1377-6 (2014).","journal-title":"J. Neurooncol."},{"key":"37975_CR49","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s11102-015-0698-6","volume":"19","author":"Y Miao","year":"2016","unstructured":"Miao, Y. et al. A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34\/CD105) expression on pituitary adenoma invasion. Pituitary 19, 194\u2013201, https:\/\/doi.org\/10.1007\/s11102-015-0698-6 (2016).","journal-title":"Pituitary"},{"key":"37975_CR50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2174\/157016112798829742","volume":"10","author":"K Tziomalos","year":"2012","unstructured":"Tziomalos, K., Athyros, V. G., Karagiannis, A. & Mikhailidis, D. P. Lipid lowering agents and the endothelium: an update after 4 years. Curr. Vasc. Pharmacol. 10, 33\u201341 (2012).","journal-title":"Curr. Vasc. Pharmacol."},{"key":"37975_CR51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3109\/08037051.2014.972816","volume":"24","author":"T Celik","year":"2015","unstructured":"Celik, T. et al. Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: comparative effects of amlodipine and valsartan. Blood Press. 24, 55\u201360, https:\/\/doi.org\/10.3109\/08037051.2014.972816 (2015).","journal-title":"Blood Press."},{"key":"37975_CR52","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604\u2013612 (2009).","journal-title":"Ann. Intern. Med."},{"key":"37975_CR53","doi-asserted-by":"publisher","first-page":"e0190068","DOI":"10.1371\/journal.pone.0190068","volume":"12","author":"MH Kim","year":"2017","unstructured":"Kim, M. H. et al. Urinary exosomal viral microRNA as a marker of BK virus nephropathy in kidney transplant recipients. PloS one 12, e0190068, https:\/\/doi.org\/10.1371\/journal.pone.0190068 (2017).","journal-title":"PloS one"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37975-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37975-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37975-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T06:01:24Z","timestamp":1671256884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37975-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,12]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["37975"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-37975-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,12]]},"assertion":[{"value":"17 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1854"}}